NCT00000737: A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome |
|
|
| Completed | 1/2 | 56 | US | Dronabinol, Megestrol acetate | National Institute of Allergy and Infectious Diseases (NIAID), Roxane Laboratories, Bristol-Myers Squibb | Cachexia, HIV Infections, HIV Wasting Syndrome | | | | |
